What considerations should be addressed when prescribing pain medication and developing treatment plans for orthopedic patients, including state opioid prescribing guidelines, evidence‑based strategies, patient education, and family/social support?

Pain Management in Orthopedic Patients: Evidence-Based Prescribing Framework

Maximize nonopioid therapies first—they are equally or more effective than opioids for most orthopedic conditions including fractures, sprains, and routine surgeries—and only prescribe opioids when benefits clearly outweigh risks, using immediate-release formulations at ≤50 morphine milligram equivalents (MME) daily for ≤3-7 days. 1

Core Prescribing Algorithm

Step 1: Initial Pain Management Strategy

Start with multimodal analgesia combining at least two nonopioid approaches 2, 3:

Pharmacologic options:

• Scheduled acetaminophen (not PRN)
• NSAIDs (oral or topical) unless contraindicated
• Consider gabapentinoids for neuropathic components

Physical interventions:

• Ice application
• Elevation
• Immobilization or controlled mobilization
• Transcutaneous electrical nerve stimulation (TENS) 3

Regional anesthesia:

• Nerve blocks (e.g., transversus abdominis plane blocks for appropriate surgeries)
• Local infiltration anesthesia 4, 5

Step 2: Risk Stratification Before Any Opioid Prescription

Screen every patient using validated tools to identify high-risk individuals 5:

• Prior opioid use history
• Substance use disorder history
• Mental health conditions (depression, anxiety)
• Query your state's Prescription Drug Monitoring Program (PDMP) mandatory 3

Step 3: When Opioids Are Necessary

Appropriate indications 1:

• Severe traumatic injuries (crush injuries, burns)
• Invasive surgeries with expected moderate-to-severe postoperative pain
• When NSAIDs contraindicated or ineffective

Prescribing parameters 1, 4:

• Formulation: Immediate-release only (never extended-release for acute pain)
• Dose: ≤50 MME daily (e.g., oxycodone 5mg = 7.5 MME; hydrocodone 5mg = 5 MME)
• Duration: 3-7 days maximum for most procedures 1
• Instructions: PRN dosing only ("take one tablet every 4-6 hours as needed"), never scheduled around-the-clock 1
• Quantity: Prescribe only expected need; data shows 79.6% adherence to on-target prescribing is achievable 4

Step 4: State-Specific Compliance

Incorporate your state's opioid prescribing laws, which typically mandate:

• PDMP checks before prescribing
• Maximum initial prescription limits (commonly 5-7 days)
• Patient-prescriber agreements for controlled substances
• Mandatory prescriber education (evidence shows state policies combined with education reduced prescribing by 26-40%) 6

Special Population: Patients with Opioid Use Disorder (OUD)

Critical principle: Patients on medication-assisted treatment (methadone, buprenorphine, naltrexone) require specialized perioperative management 7.

Management approach:

• Continue baseline OUD medications throughout perioperative period—never discontinue 7
• Recognize opioid-induced hyperalgesia: chronic opioid exposure causes neuroplastic changes that increase pain sensitivity and reduce opioid efficacy 7
• Consult pain management specialists preoperatively when possible 7
• Use higher multimodal analgesia intensity (regional blocks, ketamine infusions, higher-dose NSAIDs)
• If additional opioids needed, prescribe separate from baseline OUD medication
• Single prescriber rule: One clinician manages all opioid prescriptions 3

Pitfall to avoid: Undertreating pain in OUD patients leads to treatment disruption, mistrust, and potential relapse; overtreating risks respiratory depression and overdose 7.

Evidence-Based Systems Solutions

Reducing Pharmaceutical Industry Influence

1. Institutional prescribing protocols: Standardized order sets based on procedure type reduce variation and excess prescribing 6, 4
2. Clinical decision support: Electronic alerts for high-risk prescribing patterns 3
3. Departmental policies: Procedure-specific opioid limits (e.g., arthroscopy: 0-15 pills; total joint: 30-40 pills) 5
4. Eliminate industry-sponsored pain education: Use only evidence-based guidelines from AAOS, CDC, OTA 2, 1, 3

Quality Improvement Metrics

Track and audit 4:

• Percentage prescriptions ≤50 MME daily
• Multimodal analgesia utilization rate (target >75%)
• PDMP query compliance (target 100%)
• Patient-reported pain control at first postoperative visit

Documentation gap identified: 57% of practices fail to document continued opioid use at follow-up and 94% don't record pill consumption 4—implement standardized documentation.

Patient Education Requirements

Preoperative counseling must include 1, 5:

• Realistic pain expectations: "You will have discomfort, but it should be manageable with multimodal therapy"
• Opioid risks: addiction (3-7% risk after surgery), respiratory depression, constipation, falls 4
• Nonopioid effectiveness: "NSAIDs work as well as opioids for your type of surgery" 1
• Safe storage and disposal: lockbox storage, return unused pills to pharmacy take-back programs
• Signs of complications requiring immediate attention

Delivery methods 5:

• Multimedia presentations in waiting rooms
• Written handouts with procedure-specific guidance
• Verbal reinforcement by surgeon and nursing staff

Evidence: Patient education initiatives significantly decrease postoperative opioid consumption 5.

Family and Social Support Integration

Preoperative family meeting:

• Educate family on multimodal pain plan and realistic expectations
• Assign family member as "medication manager" for high-risk patients
• Provide family with warning signs of oversedation (respiratory rate <10, difficult to arouse)

Postoperative support structure:

• Schedule follow-up within 7-14 days to reassess pain and opioid need
• Connect patients with inadequate pain control to pain specialists, not automatic refills
• For patients with OUD: coordinate with addiction medicine, ensure continuity with outpatient treatment programs 7
• Psychosocial interventions: anxiety reduction (aromatherapy has evidence), cognitive behavioral approaches for catastrophizing 3

Social determinants: Address barriers to nonopioid therapies (cost of NSAIDs, access to physical therapy, ice availability at home).

Implementation Pitfalls

1. Avoid blanket "no opioid" policies: Some patients genuinely need short-term opioids; denying them causes harm 1
2. Don't prescribe "just in case": Only prescribe for anticipated severe pain 1
3. Refill strategy: Offer refill option rather than large initial prescription, but require office contact/visit to assess need 5
4. Monitor sedation, not just pain: Use validated scales for inpatients to prevent respiratory depression 3
5. Avoid extended-release formulations: No role in acute orthopedic pain 1

The evidence strongly supports that most orthopedic pain is manageable without opioids or with minimal short-term use when a comprehensive multimodal approach is implemented systematically 2, 1. State-level policies combined with prescriber education have demonstrated 20-30% reductions in opioid-related harms 6, 8.